Erythropoietins are accepted for the management of anaemia which develops during treatment with peginterferon and ribavirin for chronic hepatitis C virus infection.
| Filename: | Erythropoietins for anaemia during antiviral treatment for chronic hepatitis C |
| Filetype: | |
| Filesize: | 53.56 KB |
| Date uploaded: | 7th September 2011 |
| Date updated: | 8th December 2022 |
